Storys aus Lugano,

European Society for Medical Oncology (ESMO)

ESMO releases first-ever guidance for safe use of AI Language Models in cancer care

Cornèr Banca SA

The Cornèr Group consolidates its growth

Lugano (ots) - Faced with an uncertain economic environment, driven by a restrictive monetary policy and declining interest rates, the Cornèr Group maintained a stable growth trajectory thanks to its prudent philosophy and solid equity position, with capital resources rising to CHF 1,223 million (+5.9 %). The 73rd financial year closed with a balance sheet ...

Cornèr Banca SA

Now also on mobile phones: Cornèr Group launches enhanced version of the B2B payment solution Visa Commercial Pay

Lugano/Zurich (ots) - Cornèr Group, Europe's first banking group, has launched Visa Commercial Pay (VCP) for mobile devices. This innovative solution allows companies to use virtual cards not only online, but also on smartphones and smartwatches. The ...

Lugano Elegance

Rudolph Valentino's Isotta Fraschini Awarded Best in Show at the Lugano Elegance Concours d'Elegance 2024

Lugano Elegance

Join Us for Lugano Elegance: Classic Cars, Charity, and Community/ We are excited to invite car enthusiasts and the general public to our classic car show in the scenic Piazzas of Lugano in May 18th.

Cornèr Banca SA

Solid growth for Cornèr Group

Lugano (ots) - Faced with an uncertain geopolitical and economic situation, Cornèr Group's prudent policy and long-held pragmatic approach have once again proven to be winning qualities. Cornèr Group's 72nd financial year closed with revenues reaching CHF 506 million (+16 %) and a net profit of CHF 74.9 million (+41 %). This result allows the Group to further strengthen its capital solidity with its capital ...

Cornèr Banca SA

Good Results for the Cornèr Group

Lugano (ots) - Following a highly turbulent year, which saw the outbreak of the war in Ukraine and abrupt interest rate rises by the main central banks around the world, the Cornèr Group has now posted good results in its 71st Annual Report. Revenues increased to CHF 436 million, whilst the net profit rose to CHF 53.2 million, representing a strong increase compared to the previous year (CHF 22.7 million). ...

Cornèr Banca SA

Cornèr Group launches Visa Commercial Pay as first banking group in Europe

Lugano/Zurich (ots) - Starting from Switzerland, Cornèr Group introduces Visa Commercial Pay (VCP), supporting companies to quickly digitize B2B payments. The increasing pace of digitalisation in business processes creates new demands for payment capabilities of companies. A comprehensivesolution by ...

Luxochain

ENG - Temera, Luxochain & Polygon, announce the collaboration with Bulgari for the launch of the new Octo Finissimo Ultra

Lugano, Switzerland (ots/PRNewswire) - Temera, Luxochain and Polygon are pleased to announce their role as partners for the launch project of the new model Octo Finissimo Ultra, available in a limited edition of only 10 pieces. Bulgari with this initiative masters again its leadership as innovator in the hard luxury ...

Luxochain SA

Lugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City

Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, has promoted an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. Lugano is increasingly a Blockchain & Crypto-Friendly City. After the launch at the ...

Luxochain SA

Lugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City

Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, has promoted an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. Lugano is increasingly a Blockchain & Crypto-Friendly City. After the launch at the ...

Luxochain SA

Lugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City.

Lugano, Switzerland (ots/PRNewswire) - From 15-21 November Lugano Living Lab, the digital innovation laboratory of the City of Lugano, promotes an unprecedented exhibition that explores the fascinating world of NFT and Crypto Art with an exhibition, events and dedicated workshops. An unmissable opportunity to look into this new sector of digital art, discover ...

European Society for Medical Oncology (ESMO)

Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Research

European Society for Medical Oncology (ESMO)

2

ESMO supports women in South Africa to become autonomous workers

European Society for Medical Oncology (ESMO)

Breast cancer patients use Twitter as a non-medical forum to share their experiences

Lugano/Munich (ots) - Twitter is a place where many cancer patients share and discuss their experiences, a study at the ESMO 2018 Congress reveals, based on analysis of the contents of over 6,000 tweets and retweets about breast cancer. The study was part of a larger, multidisciplinary project to observe the presence of different diseases on social media. The data ...

European Society for Medical Oncology (ESMO)

ESMO Publishes New Position Paper on Supportive and Palliative Care

Lugano (ots) - ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care, calling attention to the evolving and growing gap between the needs of cancer patients and the actual provision of patient-centred care. "New studies show that there may be a gap between what doctors think is important for patients, and what patients really need. With this position ...

European Society for Medical Oncology (ESMO)

CAREFOR calls on EU to safeguard independent academic research

Helsinn Healthcare SA

Helsinn Group and MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia

Lugano, Switzerland and San Diego (ots/PRNewswire) - Phase 2 study results presented at American Society of Hematology Annual Meeting on Saturday, December 3, 2016 Global Phase 3 study site recruitment is ongoing Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, ...

Helsinn Healthcare SA

Helsinn Group and MEI Pharma Announce Long-Term Survival and Response Data from Phase II Clinical Study of Pracinostat in Acute Myeloid Leukemia Accepted for Oral Presentation at Upcoming American Society of Hematology Annual Meeting

Lugano, Switzerland and San Diego (ots/PRNewswire) - Data to be presented on December 3, 2016; Abstract now available online Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel ...

Helsinn Healthcare SA

Helsinn Group Introduces Helsinn Investment Fund

Lugano, Switzerland (ots/PRNewswire) - ~ Helsinn Group creates new investment fund in 40th anniversary year ~ ~ The new fund will focus on supporting early-stage investment opportunities in areas of high unmet patient need ~ Helsinn, the Swiss Pharmaceutical Group focused on building quality cancer care, today introduces Helsinn Investment Fund S.A. ("the Fund"), a fund focused on early-stage investment opportunities in ...

Helsinn Healthcare SA

Helsinn Celebrates its 40th Anniversary

Lugano, Switzerland (ots/PRNewswire) - ~ 40 years helping patients achieve a better quality of life ~ Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, is delighted to launch its 40th anniversary celebrations in San Francisco, US, at the time of the JP Morgan 34th Annual Healthcare Conference. Helsinn believes its core values of respect, integrity and quality have underpinned four decades of ...

European Society for Medical Oncology (ESMO)

ESMO announces annual medical oncology congress platform in Europe from 2016

Lugano, Switzerland (ots) - The European Society for Medical Oncology, the pan-European association representing medical oncologists in Europe and beyond, has announced that it will be organising an annual Congress in Europe from 2016. A record 19,809 participants from 134 countries gathered at ESMO 2014 in Madrid to hear the results of trials which included ...

Helsinn Healthcare SA

Eisai Oncology & Helsinn Group to Present New CINV Research at 2014 International Symposium on Supportive Care in Cancer

Woodcliff Lake, NJ, and Lugano, Switzerland (ots) - Eisai Inc. and Helsinn Group announced today that several abstracts highlighting data analyses of NEPA, an investigational oral fixed- dose combination of netupitant and palonosetron being evaluated for the prevention of chemotherapy-induced nausea and vomiting ...

Helsinn Healthcare SA

Helsinn Therapeutics (U.S.), Inc. Strengthens its Board of Directors

Lugano, Switzerland (ots) - Helsinn Group, the Company focused on building quality cancer care, announced today the appointment of Dr. Philip S. Schein, to the Board of Directors of its U.S. subsidiary, Helsinn Therapeutics Inc. ("HTU"), effective 8 May 2014. Dr. Philip Schein was the former Founder, Chairman and CEO of US Biosciences, Inc., and Chair of the Clinical Investigations Committee of the National Cancer ...